VLA 0.00% $1.75 viralytics limited

Ann: Viralytics to Present New CAVATAK Clinical Data at AACR, page-7

  1. 12,359 Posts.
    lightbulb Created with Sketch. 1105
    Hi Bripoz,
    Lets hope this presentation can clinch us a deal or lead to a crack at a phase 3 approval or bloody something.
    We need some direction or we are always in the sights of the traders.
    Nice claw back today but by rights we should be around the $1 2o mark imo.
    Aloha.
 
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.